ArticleBMJ open2024

Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors.

Tommaso Clemente et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.